Solicitation NOI- SS FDA-CDER-25-130459.pdf
PDF 67 KB Posted
- Solicitation number
- FDA-CDER-25-130459
About this file
This document is a Notice of Intent to Sole Source issued by the Food and Drug Administration (FDA) on September 8, 2025. The FDA intends to award a Firm Fixed Price contract to Roberts Oxygen Co Inc., located in Derwood, MD, under FAR Part 6.302-1, which allows for a sole source procurement when only one responsible source can satisfy agency requirements.
The notice provides a response deadline of September 12, 2025, at 3:00 PM EST for potential vendors to submit capability statements demonstrating their ability to meet the contract requirements. The FDA anticipates issuing the award to Roberts Oxygen within five days of the notice, unless another organization can prove it can fulfill the contract. Interested parties should email their capability statements to Rodney D. Aytch at rodney.aytch@fda.hhs.gov. The specific contract details are referenced in an attached Statement of Work, which was not included in the provided document.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Requirements Document FDA-CDER-25-130459.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
September 8, 2025 Notice of Intent to Sole Source
Roberts Oxygen
FDA-CDER-25-130459
The Food and Drug Administration (FDA) intends to award a Sole Source Firm Fixed Price contract order to Roberts
Oxygen Co Inc., 15830 Redland Rd., Derwood, MD 20855-2203
In accordance with FAR Part 6.302-1 (a) (2)(ii) which states” Only one responsible source and no other supplies or services will satisfy agency requirement”.
The purpose of this notice is to inform the public that the Food and Drug Administration (FDA) anticipates issuing a Firm Fixed Price contract.
MINIMUM REQUIREMENTS:
See Attached Statement of Work
This notice is not a request for competitive proposals. However, any party that believes it can meet this requirement as stated herein may submit a written capability statement that clearly supports and demonstrates their ability to perform the requirement.
Capability statements must be received by the response date and time of this notice. Submissions will be reviewed to determine if they can meet the requirement. A determination by the Government to compete this proposed contract based upon responses to this notice is solely within the discretion of the
Government.
It is anticipated that an award will be issued to Roberts Oxygen CO Inc within approximately five (5) days after the date of this notice unless the Government determines that any other organization has the capability to meet this requirement.
Response Date: September 12, 2025, by 3.00PM EST. Please email responses to Rodney D. Aytch
– rodney.aytch@fda.hhs.gov.
Rodney D. Aytch
Contract Specialist mailto:rodney.aytch@fda.hhs.gov.
File details come from the government source that posted it. Updated .